NARA Discovery
Article Details
← Back to Search Results
Journal Article

Modifying recombinant purple acid phosphatase using computational design

Aishwarya Venkatramani; Montader Ali; Olga Predeina; Jennifer C. Molloy; Pietro Sormanni; Elizabeth A. H. Hall
European Biophysics Journal · Vol. 55, Issue 3 · pp. 499-511 · 2026

Abstract

Enhancing protein stability while maintaining activity is a long-standing challenge in protein engineering, as modifications that benefit one property often compromise another. In this study, we leveraged a computational design strategy, CamSol Combination, to make a first step to improve the stability of purple acid phosphatase (PAP), a metalloprotein known for its distinctive pink color. PAP serves as a challenging model for engineering due to its complex redox-active site and the incorporation of iron ions critical to its function. Five mutations were introduced—H22R, A24P, F54P, H197P, and T208R—targeted to enhance thermal stability, as suggested by the computational design pipeline, while avoiding key functional regions. Experimental validation confirmed the choice of mutations with a 5 °C increase in thermal stability and retained enzymatic activity across a slightly expanded pH range. The mutations introduced subtle shifts in the enzyme’s spectral and redox behavior, consistent with a lower energy of the oxidized state, and with dynamic light scattering data suggesting low aggregation. These results highlight the potential of computational approaches like the CamSol Combination to streamline protein engineering by enabling multi-trait optimization.

Bibliographic Information

JournalEuropean Biophysics Journal
PublisherSpringer
Publication Date2026-06-01
Publication Year2026
Volume55
Issue3
Pages499-511
Document TypeJournal Article
Print ISSN0175-7571
eISSN1432-1017
DOI10.1007/s00249-025-01779-3

Access Information

NARA Access Coverage1974-01-01~Current
Journal Homepagehttps://www.springer.com/journal/249
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.